AU2636600A - Method for the prevention or reduction of cardiovascular events associated with coronary intervention - Google Patents
Method for the prevention or reduction of cardiovascular events associated with coronary intervention Download PDFInfo
- Publication number
- AU2636600A AU2636600A AU26366/00A AU2636600A AU2636600A AU 2636600 A AU2636600 A AU 2636600A AU 26366/00 A AU26366/00 A AU 26366/00A AU 2636600 A AU2636600 A AU 2636600A AU 2636600 A AU2636600 A AU 2636600A
- Authority
- AU
- Australia
- Prior art keywords
- days
- coronary intervention
- treatment period
- pharmaceutically acceptable
- dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11846299P | 1999-02-03 | 1999-02-03 | |
| US60118462 | 1999-02-03 | ||
| PCT/US2000/002622 WO2000045811A1 (en) | 1999-02-03 | 2000-02-02 | Method for the prevention or reduction of cariovascular events associated with coronary intervention |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2636600A true AU2636600A (en) | 2000-08-25 |
Family
ID=22378750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU26366/00A Abandoned AU2636600A (en) | 1999-02-03 | 2000-02-02 | Method for the prevention or reduction of cardiovascular events associated with coronary intervention |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1171116A4 (hu) |
| JP (1) | JP2002536327A (hu) |
| KR (1) | KR20010101934A (hu) |
| CN (1) | CN1345237A (hu) |
| AU (1) | AU2636600A (hu) |
| BR (1) | BR0007921A (hu) |
| CA (1) | CA2361581A1 (hu) |
| CO (1) | CO5150206A1 (hu) |
| HK (1) | HK1045104A1 (hu) |
| HU (1) | HUP0200129A3 (hu) |
| IL (1) | IL144721A0 (hu) |
| MX (1) | MXPA01007835A (hu) |
| NO (1) | NO20013788L (hu) |
| PL (1) | PL351397A1 (hu) |
| TR (1) | TR200102245T2 (hu) |
| WO (1) | WO2000045811A1 (hu) |
| ZA (1) | ZA200106353B (hu) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2617407B2 (ja) * | 1992-09-14 | 1997-06-04 | キッセイ薬品工業株式会社 | 血管内膜細胞過剰増殖疾患の予防および治療剤 |
| US5693337A (en) * | 1994-07-13 | 1997-12-02 | Wakamoto Pharmaceutical Co., Ltd. | Stable lipid emulsion |
| WO1997009301A1 (fr) * | 1995-09-07 | 1997-03-13 | Kissei Pharmaceutical Co., Ltd. | Derives de 2-acylaminobenzamide, preventif et remede contre des maladies causees par une surmultiplication des cellules vasculaires de l'intima |
| US6019104A (en) * | 1996-12-30 | 2000-02-01 | Kissei Pharmaceutical Co., Ltd. | Method for the treatment or prevention of restenosis associated with coronary intervention |
-
2000
- 2000-02-02 CA CA002361581A patent/CA2361581A1/en not_active Abandoned
- 2000-02-02 EP EP00904640A patent/EP1171116A4/en not_active Withdrawn
- 2000-02-02 BR BR0007921-9A patent/BR0007921A/pt not_active Application Discontinuation
- 2000-02-02 AU AU26366/00A patent/AU2636600A/en not_active Abandoned
- 2000-02-02 WO PCT/US2000/002622 patent/WO2000045811A1/en not_active Application Discontinuation
- 2000-02-02 PL PL00351397A patent/PL351397A1/xx not_active Application Discontinuation
- 2000-02-02 CN CN00803384A patent/CN1345237A/zh active Pending
- 2000-02-02 HU HU0200129A patent/HUP0200129A3/hu unknown
- 2000-02-02 TR TR2001/02245T patent/TR200102245T2/xx unknown
- 2000-02-02 JP JP2000596931A patent/JP2002536327A/ja not_active Withdrawn
- 2000-02-02 IL IL14472100A patent/IL144721A0/xx unknown
- 2000-02-02 KR KR1020017009744A patent/KR20010101934A/ko not_active Application Discontinuation
- 2000-02-02 MX MXPA01007835A patent/MXPA01007835A/es unknown
- 2000-02-03 CO CO00006604A patent/CO5150206A1/es unknown
-
2001
- 2001-08-02 NO NO20013788A patent/NO20013788L/no not_active Application Discontinuation
- 2001-08-02 ZA ZA200106353A patent/ZA200106353B/en unknown
-
2002
- 2002-07-12 HK HK02105201.2A patent/HK1045104A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR200102245T2 (tr) | 2002-05-21 |
| ZA200106353B (en) | 2002-08-02 |
| NO20013788L (no) | 2001-09-28 |
| IL144721A0 (en) | 2002-06-30 |
| HK1045104A1 (zh) | 2002-11-15 |
| KR20010101934A (ko) | 2001-11-15 |
| CA2361581A1 (en) | 2000-08-10 |
| EP1171116A1 (en) | 2002-01-16 |
| BR0007921A (pt) | 2002-09-10 |
| CO5150206A1 (es) | 2002-04-29 |
| PL351397A1 (en) | 2003-04-07 |
| CN1345237A (zh) | 2002-04-17 |
| MXPA01007835A (es) | 2002-04-24 |
| HUP0200129A2 (hu) | 2002-05-29 |
| EP1171116A4 (en) | 2004-11-17 |
| NO20013788D0 (no) | 2001-08-02 |
| HUP0200129A3 (en) | 2003-06-30 |
| WO2000045811A1 (en) | 2000-08-10 |
| JP2002536327A (ja) | 2002-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5385935A (en) | Method for the inhibition of restenosis associated with coronary intervention | |
| TW389696B (en) | Accelerated release composition containing bromocriptine | |
| DE69409913T2 (de) | Methode zur Hemmung der Proliferation weiche Muskelzellen und der Restenose | |
| RU2221563C2 (ru) | Фармацевтическая композиция для лечения болезни паркинсона и синдромов паркинсона, способ ее получения, способ лечения болезни паркинсона и синдромов паркинсона | |
| WO2005084392A2 (en) | 4-methylpyrazole formulations for inhibiting ethanol intolerance | |
| JPH02223521A (ja) | 血清コレステロール低下剤 | |
| JP3007992B2 (ja) | （ｒ）−アムロジピンによる平滑筋細胞の遊走の抑制 | |
| AU2007234917B2 (en) | Renin inhibitors for the treatment of hypertension | |
| AU2636600A (en) | Method for the prevention or reduction of cardiovascular events associated with coronary intervention | |
| AU2978500A (en) | Method for the prevention or reduction of cardiovascular events associated with coronary intervention | |
| JPH04338328A (ja) | 血管形成阻害剤として有用なベンゾイルカルビノール及びそのエステル | |
| WO2001062241A1 (en) | Method for the prevention or reduction of vascular access dysfunction | |
| WO2001097798A1 (en) | Method for the prevention or reduction of cardiovascular events associated with coronary intervention | |
| KR100817932B1 (ko) | 베르바민을 유효성분으로 포함하는 혈관 재협착 예방제 | |
| CA2465807A1 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer | |
| US20070254956A1 (en) | Medicament for Therapeutic and/or Preventive Treatment of Restenosis or Reocclusion After Vascular Recanalization Operation | |
| AU627277B2 (en) | A method of treatment or prevention of post-ptca restenosis by post-ptca restenosis inhibitor | |
| AU701287B2 (en) | The pharmacological use of certain cystine derivatives | |
| US20080139668A1 (en) | Pharmaceutical composition for obovatol for the prevention and treatment of restenosis | |
| US5354770A (en) | Using imidazolyl tetrahydronaphthalene carboxylic acids to inhibit restenosis | |
| JPH1036258A (ja) | 新規な抗痙攣性及び抗炎症性組成物並びにそれらの製造方法 | |
| KR100806541B1 (ko) | 아세클로페낙을 함유하는 제어 방출성 제제 | |
| WO2002056941A2 (en) | Method for the treatment of peripheral vascular disease | |
| JPH02289515A (ja) | Ｐｔｃａ後の再狭窄抑制剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DA3 | Amendments made section 104 |
Free format text: THE NATURE OF THE AMENDMENT IS: AMEND INVENTION TITLE TO READ METHOD FOR THE PREVENTION OR REDUCTION OF CARDIOVASCULAR EVENTS ASSOCIATED WITH CORONARY INTERVENTION |
|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |